Novel electrospun chitosan/PEO membranes for more predictive nanoparticle transport studies at biological barriers
Source abstract
Abstract
The design of safe and effective nanoparticles (NPs) for commercial and medical applications requires a profound understanding of NP translocation and effects at biological barriers. To gain mechanistic insights, physiologically relevant and accurate human in vitro biobarrier models are indispensable. However, current transfer models largely rely on artificial porous polymer membranes for the cultivation of cells, which do not provide a close mimic of the natural basal membrane and intrinsically provide limited permeability for NPs. In this study, electrospinning is exploited to develop thin chitosan/polyethylene oxide (PEO) membranes with a high porosity and nanofibrous morphology for more predictive NP transfer studies. The nanofiber membranes allow the cultivation of a tight and functional placental monolayer (BeWo trophoblasts). Translocation studies with differently sized molecules and NPs (Na-fluorescein; 40 kDa FITC-Dextran; 25 nm PMMA; 70, 180 and 520 nm polystyrene NPs) across empty and cell containing membranes reveal a considerably enhanced permeability compared to commercial microporous membranes. Importantly, the transfer data of NPs is highly similar to data from ex vivo perfusion studies of intact human placental tissue. Therefore, the newly developed membranes may decisively contribute to establish physiologically relevant in vitro biobarrier transfer models with superior permeability for a wide range of molecules and particles.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Polymer Surface Interaction Studies · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Empa, Swiss Federal Laboratories for Materials Science and Technology, Laboratory for Particles-Biology Interactions, 9014 St. Gallen, Switzerland
ETH Zürich, Responsive Biomedical Systems Lab, 8093 Zürich, Switzerland
Empa, Swiss Federal Laboratories for Materials Science and Technology, Laboratory for Biomimetic Membranes and Textiles, 9014 St. Gallen, Switzerland
References (77)
Show source-provided references
1. N.Strambeanu , L.Demetrovici and D.Dragos , in Nanoparticles’ Promises and Risks: Characterization, Manipulation, and Potential Hazards to Humanity and the Environment , ed. M. Lungu , A. Neculae , M. Bunoiu and C. Biris , Springer , 2015 , pp. 9–19 , 10.1007/978-3-319-11728-7_210.1007/978-3-319-11728-7_2 ↗
2. M.Hoover , D.Myers , L. J.Cash , R.Guilmette , W.Kreyling , G.Oberdorster and R.Smith , Radiation Safety Aspects of Nanotechnology , United States , 201710.2172/1351238 ↗
3. Rönkkö · J. Alzheimer's Dis. · 2019 · 72 · 1510.3233/JAD-190170 ↗
4. Stark · Chem. Soc. Rev. · 2015 · 44 · 579310.1039/C4CS00362D ↗
5. He · J. Food Drug Anal. · 2016 · 24 · 67110.1016/j.jfda.2016.06.001 ↗
6. Raj · J. Pharm. Bioallied Sci. · 2012 · 4 · 18610.4103/0975-7406.99016 ↗
7. M.Mozafari , J.Rajadas and D. L.Kaplan , in Nanoengineered Biomaterials for Regenerative Medicine , ed. M. Mozafari , J. Rajadas and D. Kaplan , Elsevier , 2019 , pp. 1–11 , 10.1016/B978-0-12-813355-2.00001-610.1016/B978-0-12-813355-2.00001-6 ↗
8. Gavilán · Chem. Soc. Rev. · 2021 · 50 · 1161410.1039/D1CS00427A ↗
9. Davis · Biophys. J. · 2020 · 118 · 150210.1016/j.bpj.2020.01.028 ↗
10. Pouliquen · Magn. Reson. Imaging · 1991 · 9 · 27510.1016/0730-725X(91)90412-F ↗
11. Hoet · J. Nanobiotechnol. · 2004 · 2 · 1210.1186/1477-3155-2-12 ↗
12. Fröhlich · Arch. Toxicol. · 2016 · 90 · 229710.1007/s00204-016-1765-0 ↗
13. Landsiedel · Arch. Toxicol. · 2012 · 86 · 102110.1007/s00204-012-0858-7 ↗
14. Zhou · J. Controlled Release · 2018 · 270 · 29010.1016/j.jconrel.2017.12.015 ↗
15. Grabrucker · Tissue Barriers · 2016 · 4 · e115356810.1080/21688370.2016.1153568 ↗
16. Pietroiusti · Small · 2013 · 9 · 155710.1002/smll.201201463 ↗
17. Lan · Nanomedicine · 2012 · 7 · 57910.2217/nnm.12.20 ↗
18. Muoth · Nanomedicine · 2016 · 11 · 94110.2217/nnm-2015-0012 ↗
19. Krug · Angew. Chem., Int. Ed. · 2011 · 50 · 126010.1002/anie.201001037 ↗
20. Grafmüller · J. Visualized Exp. · 2013 · 5040110.3791/50401 ↗
21. Hirn · Beilstein J. Nanotechnol. · 2014 · 5 · 244010.3762/bjnano.5.253 ↗
22. M. P.Tibbe , A. D.van der Meer , A.van den Berg , D.Stamatialis and L. I.Segerink , Biomedical Membranes and (Bio)Artificial Organs , World Scientific , 2017 , vol. 2 , pp. 295–321
23. Blundell · Lab Chip · 2016 · 16 · 306510.1039/C6LC00259E ↗
24. Lee · J. Matern.-Fetal Neonat. Med. · 2016 · 29 · 104610.3109/14767058.2015.1038518 ↗
25. van Meer · Biochem. Biophys. Res. Commun. · 2017 · 482 · 32310.1016/j.bbrc.2016.11.062 ↗
26. Toepke · Lab Chip · 2006 · 6 · 148410.1039/b612140c ↗
27. Wang · Ann. Biomed. Eng. · 2012 · 40 · 186210.1007/s10439-012-0562-z ↗
28. Dekali · Toxicol. Rep. · 2014 · 1 · 15710.1016/j.toxrep.2014.03.003 ↗
29. George · Toxicol. In Vitro · 2015 · 29 · 5110.1016/j.tiv.2014.08.003 ↗
30. Wick · Environ. Health Perspect. · 2010 · 118 · 43210.1289/ehp.0901200 ↗
31. Aengenheister · Sci. Rep. · 2018 · 8 · 538810.1038/s41598-018-23410-6 ↗
32. K.Feltz , E.Growney Kalaf , C.Chen , R.Scott Martin and S.Sell , A review of electrospinning manipulation techniques to direct fiber deposition and maximize pore size , 2017
33. Rnjak-Kovacina · Tissue Eng., Part B · 2011 · 17 · 36510.1089/ten.teb.2011.0235 ↗
34. Nishiguchi · Biomacromolecules · 2017 · 18 · 71910.1021/acs.biomac.6b01509 ↗
35. Bösiger · Carbohydr. Polym. · 2018 · 181 · 55110.1016/j.carbpol.2017.12.002 ↗
36. VandeVord · J. Biomed. Mater. Res. · 2002 · 59 · 58510.1002/jbm.1270 ↗
37. Kean · Adv. Drug Delivery Rev. · 2010 · 62 · 310.1016/j.addr.2009.09.004 ↗
38. Ajalloueian · BioMed Res. Int. · 2014 · 2014 · 47528010.1155/2014/475280 ↗
39. T.Cunha , B.Teixeira , B.Santos , M.Almeida , G.Dias and J.das Neves , Chitosan–Based Systems for Biopharmaceuticals , 2012 , pp. 75–92 , 10.1002/9781119962977.ch510.1002/9781119962977.ch5 ↗
40. Croisier · Eur. Polym. J. · 2013 · 49 · 78010.1016/j.eurpolymj.2012.12.009 ↗
41. Pakravan · Polymer · 2011 · 52 · 481310.1016/j.polymer.2011.08.034 ↗
42. Notter · Transl. Psychiatry · 2018 · 8 · 19310.1038/s41398-018-0251-2 ↗
43. Aengenheister · Placenta · 2021 · 104 · 19910.1016/j.placenta.2020.12.014 ↗
44. Dugershaw · Part. Fibre Toxicol. · 2020 · 17 · 3110.1186/s12989-020-00359-x ↗
45. Buerki-Thurnherr · Chem. Res. Toxicol. · 2018 · 31 · 64110.1021/acs.chemrestox.8b00177 ↗
46. Wick · Environ. Health Perspect. · 2010 · 118 · 43210.1289/ehp.0901200 ↗
47. Grafmueller · Environ. Health Perspect. · 2015 · 123 · 128010.1289/ehp.1409271 ↗
48. Schmidt · J. Reprod. Immunol. · 2015 · 108 · 6510.1016/j.jri.2015.03.001 ↗
49. Carter · Biofabrication · 2017 · 9 · 01501910.1088/1758-5090/aa5ba7 ↗
50. Jud · BioRes. Open Access · 2015 · 4 · 45710.1089/biores.2015.0037 ↗
51. LeBleu · Exp. Biol. Med. · 2007 · 232 · 112110.3181/0703-MR-72 ↗
52. Jayadev · Curr. Biol. · 2017 · 27 · R20710.1016/j.cub.2017.02.006 ↗
53. Takahashi-Iwanaga · Arch. Histol. Cytol. · 1999 · 62 · 47110.1679/aohc.62.471 ↗
54. Abrams · Cell Tissue Res. · 2000 · 299 · 3910.1007/s004410050004 ↗
55. Pozzi · Matrix Biol. · 2017 · 57–58 · 110.1016/j.matbio.2016.12.009 ↗
56. Mondrinos · Lab Chip · 2017 · 17 · 314610.1039/C7LC00317J ↗
57. Cartwright · Int. J. Nanomed. · 2012 · 7 · 497
58. Feneley · Placenta · 1991 · 12 · 13110.1016/0143-4004(91)90017-A ↗
59. Jones · Placenta · 2008 · 29 · 21510.1016/j.placenta.2007.11.004 ↗
60. Bongaerts · J. Nanobiotechnol. · 2021 · 19 · 14410.1186/s12951-021-00886-5 ↗
61. Aengenheister · J. Nanobiotechnol. · 2018 · 16 · 7910.1186/s12951-018-0406-6 ↗
62. Juch · Nanotoxicology · 2018 · 12 · 9010.1080/17435390.2018.1425496 ↗
63. King · Placenta · 2000 · 21 · S11310.1053/plac.1999.0526 ↗
64. Orendi · Reproduction · 2010 · 140 · 75910.1530/REP-10-0221 ↗
65. Orendi · Placenta · 2011 · 32 · S4910.1016/j.placenta.2010.11.023 ↗
66. Li · Arch. Toxicol. · 2013 · 87 · 166110.1007/s00204-013-1074-9 ↗
67. Poulsen · Toxicol. In Vitro · 2009 · 23 · 138010.1016/j.tiv.2009.07.028 ↗
68. Eom · RSC Adv. · 2017 · 7 · 3830010.1039/C7RA06629E ↗
69. Sousa de Almeida · Chem. Soc. Rev. · 2021 · 50 · 539710.1039/D0CS01127D ↗
70. Zhao · Polym. Chem. · 2018 · 9 · 25910.1039/C7PY01603D ↗
71. Syme · Clin. Pharmacokinet. · 2004 · 43 · 48710.2165/00003088-200443080-00001 ↗
72. Grabinski · Nanotoxicology · 2016 · 10 · 74
73. Rinkenauer · J. Controlled Release · 2015 · 216 · 15810.1016/j.jconrel.2015.08.008 ↗
74. Schiffman · Biomacromolecules · 2007 · 8 · 59410.1021/bm060804s ↗
75. Schindelin · Nat. Methods · 2012 · 9 · 67610.1038/nmeth.2019 ↗
76. Grafmüller · J. Visualized Exp. · 2013 · e5040110.3791/50401 ↗
77. Aengenheister · Eur. J. Pharm. Biopharm. · 2019 · 142 · 48810.1016/j.ejpb.2019.07.018 ↗